Author

Mahmoud Nazih

Institutions: Deraya University, Ahram Canadian University

Observed institutions: Al-Ryada University for Science and Technology, Deraya University, Ahram Canadian University, Menoufia University, Assiut University

ORCID: 0009-0000-0522-399X

Observed ORCID: 0009-0000-0522-399X

OpenAlex ID: A5091975673

The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities

2025 · Hussein Sabit, Amro Adel, et al. · Cancer Letters · 119

Multifunctional properties of Phlomis aurea extracts: In-vitro antioxidant, antimicrobial, anticancer, potent repellency against two mosquito vectors and molecular docking studies

2025 · Mohamed A. M. El-Tabakh, Ahmed Z. I. Shehata, et al. · Applied Biological Chemistry · 14

Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants

2024 · Hussein Sabit, Shaimaa Abdel-Ghany, et al. · Inflammopharmacology · 10

Trastuzumab Induces Apoptosis and Cell Cycle Arrest in Triple-Negative Breast Cancer, Suggesting Repurposing Potential

2024 · Shaimaa Abdel-Ghany, Yasmin Khalid, et al. · Breast Cancer Basic and Clinical Research · 5

CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt

2023 · Ahmed Shawky, Hussein Sabit, et al. · Journal of Epidemiology and Global Health · 5

FCRL1 and BAFF mRNA Expression as Novel Diagnostic and Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma: Expression Signatures Predict R-CHOP Therapy Response and Survival

2025 · Hiba S. Al-Amodi, Hanan M. Bedair, et al. · International Journal of Molecular Sciences · 4

Genotype–Phenotype Correlation of TNF-α (−238, rs361525) and Cystatin C for Early Detection of Sepsis-Associated AKI and Its Severity in Critically Ill Neonates

2025 · Shimaa Abdelsattar, Hiba S. Al-Amodi, et al. · International Journal of Molecular Sciences · 2

Pharmacogenomics of Sorafenib in Hepatocellular Carcinoma (HCC): A LncRNA-Expression Guided Approach Using UCA1 and MALAT1 for Personalizing Therapy in a 154-Patient Cohort

2025 · Mahmoud Nazih, Imam Waked, et al. · Pharmaceuticals · 1

Real-world outcomes and predictive factors in hepatocellular carcinoma patients treated with sorafenib: an 18-month ambispective cohort analysis

2025 · Mahmoud Nazih, Ahmed I. Khoder, et al. · Future Journal of Pharmaceutical Sciences · 1

Therapeutic potential of brentuximab vedotin in breast cancer and lymphoma via targeted apoptosis and gene regulation

2025 · Abeer Ezzat, Mohga Shafiek, et al. · Scientific Reports · 1

Machine learning-based identification of targeted metabolomic biomarkers for early diagnosis and fibrosis-stage discrimination in metabolic dysfunction-associated steatotic liver disease

2026 · Shimaa Abdelsattar, Hiba S. Al-Amodi, et al. · Frontiers in Nutrition

The cross-talk between GSK-3β, RKIP, and PTEN as potential targets for therapeutic implications in cancer: a comprehensive insight

2026 · Esraa M. Mosalam, Mahmoud S. Abdallah, et al. · Journal of Pharmacy & Pharmaceutical Sciences

Correction: Vitamin D: a key player in COVID‑19 immunity and lessons from the pandemic to combat immune‑evasive variants

2025 · Hussein Sabit, Shaimaa Abdel-Ghany, et al. · Inflammopharmacology

Works count: 13

Citation count: 162

H-index: 5

I10-index: 3